Eltrombopag Mobilizes Iron In Patients With Aplastic Anemia

BLOOD(2018)

引用 35|浏览20
暂无评分
摘要
TO THE EDITOR:The thrombopoietin receptor agonist eltrombopag (EPAG) has been shown to restore hematopoiesis in patients with severe aplastic anemia (SAA) refractory to immunosuppressive therapy and to significantly improve response rates when used in combination with immunosuppressive therapy in
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要